The session below was sponsored by Takeda during the ESPID 2026 Meeting and is intended for HCPs only. *Not included in the main event CME/CPD credit.
DEN-TALK: From Dengue Urgency to Evidence-Based Prevention – Supported by Takeda (June 1, 08:30 - 09:30)
Session Description:
This session will bring together global clinical and real world perspectives to explore why dengue’s unpredictable severity demands earlier, more proactive prevention. By connecting frontline experience with emerging evidence and decision making challenges from endemic and non endemic settings, the session aims to move clinicians from urgency to confident action in routine dengue prevention conversations.
Vanesa E. Castellano
(Argentina)
Hospital de Niños Ricardo Gutierrez and Vacunar Foundation, Buenos Aires,.
Wanatpreeya Phongsamart
(Thailand)
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok.
Julio Croda
(Brazil)
Oswaldo Cruz Foundation, Federal University of Mato Grosso do Sul.
Francesca Norman
(Spain)
Ramón y Cajal University Hospital, Madrid.
Note that this recording is intended for HCPs only.
This promotional symposium has been commissioned and funded by GSK and is for Healthcare Professionals only.
*Not included in the main event CME/CPD credit.
Addressing the Need for MenB Prevention in Adolescents: Evidence, experience, and the path forward to help defeat meningitis – Supported by GSK (June 2, 11:30-12:30)
Session Description:
Adolescence is a pivotal moment — full of promise, but also a second window of vulnerability to Invasive Meningococcal Disease. Join us for a thought-provoking symposium that brings patient voices and real-world lessons together to spark change. Watch a video testimony from people and families whose lives have been impacted by meningitis. Learn how epidemiologic patterns and MenB incidence rates are relevant to a new cohort of patients entering adolescence across Europe, and beyond. Hear about Italy’s flexible, regional choices and the real-world results seen in South Australia more than five years after its adolescent program rollout. Finally, discover a path forward: GSK studies on duration of protection and the human impact on adolescents and caregivers that aim to close data gaps and accelerate adoption. This session is intended for Healthcare Professionals and Other Relevant Decision Makers. It would be of particular interest to paediatricians, clinicians, immunization leads, as well as policy makers. Leave inspired, equipped with real examples and next steps.
Teresa Bruce
(USA)
GSK Global Medical Director.
Chiara Azzari
(Italy)
University of Florence.
Giovanni Gabutti
(Italy)
University of Ferrara – Hygiene and Preventive Medicine.
Helen Marshall
(Australia)
Women’s and Children’s Hospital & College of Health.
Note that this recording is intended for HCPs only.